301211 亨迪药业
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.5243.9247.6025.5928.323
总资产报酬率 ROA (%)1.4283.6366.9815.2107.764
投入资产回报率 ROIC (%)1.5083.8717.4095.4778.244

边际利润分析
销售毛利率 (%)22.10528.84140.17228.87833.943
营业利润率 (%)9.23322.62630.96928.88425.764
息税前利润/营业总收入 (%)6.92211.37822.95515.96726.040
净利润/营业总收入 (%)7.70120.53326.56224.43022.502

收益指标分析
经营活动净收益/利润总额(%)32.56878.54096.29694.03384.775
价值变动净收益/利润总额(%)70.61318.9501.9820.0007.691
营业外收支净额/利润总额(%)-1.441-0.461-1.242-0.871-0.073

偿债能力分析
流动比率 (X)15.64011.40411.98410.66020.670
速动比率 (X)14.56910.56510.99210.11119.802
资产负债率 (%)5.3567.1917.4578.8954.614
带息债务/全部投入资本 (%)0.3620.4890.9322.9850.271
股东权益/带息债务 (%)27,346.47720,215.89110,560.3443,230.84136,672.936
股东权益/负债合计 (%)1,766.9981,290.5661,241.1041,024.2712,067.151
利息保障倍数 (X)-3.175-1.021-3.007-1.26088.477

营运能力分析
应收账款周转天数 (天)44.51340.80433.69670.74872.624
存货周转天数 (天)132.808176.813130.916100.365112.946